New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.

How a good mood could help some vaccines work better - An elevated mood could boost the effectiveness of vaccines with newer ...

Researchers found antibodies in those who reported the most positive moods were 16% higher when compared to those with lowest ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

Cell therapy and oncology–focused Carisma Therapeutics started layoffs late last year. Now the company plans to wind down ...

U.S. stock futures point lower as investors await tomorrow's announcement on reciprocal tariffs, and OpenAI announces a $40 ...

Disturbing news appears nearly daily from the federal government. Among the science-related issues, the most disturbing was ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...

As warehouses go, nuclei are more like libraries than bank vaults. Too many cellular components need access to the genome to lock it down like Fort Knox. Instead, large groupings of more than 1,000 ...

Two Wall Street analysts on Monday called on the Trump administration to "re-evaluate" Robert F. Kennedy Jr.'s role as the secretary of the Department of Health and Human Services, saying his ...

Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...